Difficulty: Medium
Average Score: 93%
Practice
A patient's antiretroviral therapy has not been as efficacious as her care team had predicted, and maraviroc (Selzentry) has consequently been added to her drug regimen. The nurse should recognize this drug as belonging to what category of antiretroviral?
Correct answer
C
Rationale
In this scenario, the correct answer is C) CCR5 antagonists, specifically maraviroc (Selzentry). Maraviroc works by targeting the CCR5 receptor on CD4 cells, blocking viral entry into the cell. This mechanism differs from the other options provided.
Option A) Fusion protein inhibitors, such as enfuvirtide, work by preventing HIV from fusing with the host cell membrane. Option B) Protease inhibitors, like lopinavir, inhibit the viral enzyme protease, preventing the maturation of new virus particles. Option D) Integrase strand transfer inhibitors, such as raltegravir, block the integration of viral DNA into the host cell genome.
Understanding the mechanism of action of each class of antiretrovirals is crucial in pharmacology to ensure appropriate selection and combination of drugs for effective treatment. CCR5 antagonists like maraviroc are especially important in cases where other antiretrovirals have not been as efficacious, as they target a different step in the HIV life cycle. This knowledge aids healthcare professionals in providing individualized patient care and achieving optimal treatment outcomes.
Option A) Fusion protein inhibitors, such as enfuvirtide, work by preventing HIV from fusing with the host cell membrane. Option B) Protease inhibitors, like lopinavir, inhibit the viral enzyme protease, preventing the maturation of new virus particles. Option D) Integrase strand transfer inhibitors, such as raltegravir, block the integration of viral DNA into the host cell genome.
Understanding the mechanism of action of each class of antiretrovirals is crucial in pharmacology to ensure appropriate selection and combination of drugs for effective treatment. CCR5 antagonists like maraviroc are especially important in cases where other antiretrovirals have not been as efficacious, as they target a different step in the HIV life cycle. This knowledge aids healthcare professionals in providing individualized patient care and achieving optimal treatment outcomes.